105 related articles for article (PubMed ID: 38515071)
1. Comparative Effectiveness of Mepolizumab, Benralizumab, and Dupilumab among Patients with Difficult-to-Control Asthma: A Multicenter Retrospective Propensity-matched Analysis.
Kearney CM; Sangani R; Shankar D; O'Connor GT; Law AC; Walkey AJ; Bosch NA
Ann Am Thorac Soc; 2024 Jun; 21(6):866-874. PubMed ID: 38241013
[No Abstract] [Full Text] [Related]
2. Smaller Differences in the Comparative Effectiveness of Biologics in Reducing Asthma-Related Hospitalizations Compared With Overall Exacerbations.
Akenroye A; Marshall J; Simon AL; Hague C; Costa R; Jamal-Allial A; McMahill-Walraven CN; Haffenreffer K; Han A; Wu AC
J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1568-1574.e2. PubMed ID: 38431251
[TBL] [Abstract][Full Text] [Related]
3. Comparative Impact of Asthma Biologics: A Nationwide US Claim-Based Analysis.
Al-Shaikhly T; Norris MR; Dennis EH; Liu G; Craig TJ
J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1558-1567. PubMed ID: 38423294
[TBL] [Abstract][Full Text] [Related]
4. Precision care in the treatment of pediatric asthma.
Mahmood L; Keskin S; Jefferson AA
Curr Opin Pediatr; 2024 Jun; 36(3):304-309. PubMed ID: 38411592
[TBL] [Abstract][Full Text] [Related]
5. Biological treatments in childhood asthma.
Nieto-García A; Nieto-Cid M; Mazón-Ramos Á
Curr Opin Allergy Clin Immunol; 2024 Jun; 24(3):114-121. PubMed ID: 38567842
[TBL] [Abstract][Full Text] [Related]
6. Real-world effectiveness of dupilumab versus benralizumab and mepolizumab.
Bleecker E; Blaiss M; Jacob-Nara J; Huynh L; Guo T; Ye M; Stanford RH; Wang Z; Soler X; Nag A; Nair R; Borsos K
Allergy Asthma Proc; 2024 May; ():. PubMed ID: 38760161
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Multiple-Flows Exhaled Nitric Oxide and Its Clinical Significance in Severe Asthmatic Patients Treated with Biologics: A Prospective Real-Life Study.
Pianigiani T; Luzzi S; Dilroba A; Meocci M; Salvadori E; Alderighi L; Bergantini L; d'Alessandro M; Sestini P; Bargagli E; Cameli P
J Asthma; 2024 Jun; ():1-18. PubMed ID: 38884564
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Effectiveness of Anti-IL-4R Therapy Following Suboptimal Response to Anti-IL-5/5R Therapy in Severe Eosinophilic Asthma.
Gates J; Hearn A; Mason T; Fernandes M; Green L; Thomson L; Roxas C; Lam J; d'Ancona G; Nanzer AM; Dhariwal J; Jackson DJ
J Allergy Clin Immunol Pract; 2024 Apr; ():. PubMed ID: 38583517
[TBL] [Abstract][Full Text] [Related]
9. Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity.
Runnstrom MC; Lamothe PA; Faliti CE; Cheedarla N; Moreno A; Suthar MS; Nahata R; Ravindran M; Haddad NS; Morrison-Porter A; Quehl H; Ramonell RP; Woodruff M; Anam F; Zhang R; Swenson C; Polito C; Neveu W; Patel R; Smirnova N; Nyugen DC; Kim C; Hentenaar I; Kyu S; Usman S; Ngo T; Guo Z; Wu H; Daiss JL; Park J; Manning KE; Wali B; Ellis ML; Sharma S; Holguin F; Cheedarla S; Neish AS; Roback JD; Sanz I; Eun-Hyung Lee F
J Allergy Clin Immunol; 2024 Jun; ():. PubMed ID: 38878020
[TBL] [Abstract][Full Text] [Related]
10. Safety of Biologics for Atopic Diseases During Pregnancy.
Shakuntulla F; Chiarella SE
J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3149-3155. PubMed ID: 35987486
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety, durability of response, cessation and switching of biologics.
Mohan A; Qiu AY; Lugogo N
Curr Opin Pulm Med; 2024 May; 30(3):303-312. PubMed ID: 38426355
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, Safety, and Continuation of Biological Therapy in Older Patients with Asthma in a Real-World Setting: A Retrospective Observational Study.
Okazaki R; Harada T; Funaki Y; Morita M; Takata M; Kohno H; Ishikawa H; Inui G; Nishigami M; Yamamoto M; Listyoko AS; Yamasaki A
Yonago Acta Med; 2024 May; 67(2):114-123. PubMed ID: 38803591
[TBL] [Abstract][Full Text] [Related]
13. Anti-IL-4R versus Anti-IL-5/5R after Anti-IL-5/5R failure in asthma: an emulated target trial.
Valery S; Simon-Tillaux N; Devouassoux G; Bonniaud P; Beurnier A; Boudjemaa A; Chenivesse C; Bourdin A; Gauquelin L; Guillo S; Taillé C; Estellat C;
J Allergy Clin Immunol; 2024 Jun; ():. PubMed ID: 38848878
[TBL] [Abstract][Full Text] [Related]
14. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma.
Scelo G; Tran TN; Le TT; Fagerås M; Dorscheid D; Busby J; Al-Ahmad M; Al-Lehebi R; Altraja A; Beastall A; Bergeron C; Bjermer L; Bjerrum AS; Cano-Rosales DJ; Canonica GW; Carter V; Charriot J; Christoff GC; Cosio BG; Denton E; Fernandez-Sanchez MJ; Fonseca JA; Gibson PG; Goh C; Heaney LG; Heffler E; Hew M; Iwanaga T; Katial R; Koh MS; Kuna P; Larenas-Linnemann D; Lehtimäki L; Mahboub B; Martin N; Matsumoto H; Menzies-Gow AN; Papadopoulos NG; Patel P; Perez-De-Llano L; Peters M; Pfeffer PE; Popov TA; Porsbjerg CM; Rhee CK; Sadatsafavi M; Taillé C; Torres-Duque CA; Tsai MJ; Ulrik CS; Upham JW; von Bülow A; Wang E; Wechsler ME; Price DB
J Allergy Clin Immunol Pract; 2024 May; ():. PubMed ID: 38768896
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Clinical Remission in Best-Performing Severe Asthmatic Patients Treated for Three Years with Mepolizumab.
Bagnasco D; Bondi B; Caminati M; Nicola S; Pini L; Milanese M; Brussino L; Senna G; Canonica GW; Braido F
Biomedicines; 2024 Apr; 12(5):. PubMed ID: 38790922
[TBL] [Abstract][Full Text] [Related]
16. Weighted Breaths: Exploring Biologic and Non-Biologic Therapies for Co-Existing Asthma and Obesity.
Pilkington AW; Buragamadagu B; Johnston RA
Curr Allergy Asthma Rep; 2024 Jun; ():. PubMed ID: 38878250
[TBL] [Abstract][Full Text] [Related]
17. Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy.
Kayser MZ; Suhling H; Fuge J; Hinze CA; Drick N; Kneidinger N; Behr J; Taube C; Welte T; Haasler I; Milger K
BMC Pulm Med; 2024 Mar; 24(1):149. PubMed ID: 38515071
[TBL] [Abstract][Full Text] [Related]
18. Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months.
Kayser MZ; Drick N; Milger K; Fuge J; Kneidinger N; Korn S; Buhl R; Behr J; Welte T; Suhling H
J Asthma Allergy; 2021; 14():863-871. PubMed ID: 34285513
[TBL] [Abstract][Full Text] [Related]
19. Matching-adjusted comparison of oral corticosteroid reduction in asthma: Systematic review of biologics.
Bourdin A; Husereau D; Molinari N; Golam S; Siddiqui MK; Lindner L; Xu X
Clin Exp Allergy; 2020 Apr; 50(4):442-452. PubMed ID: 31943429
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
